跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 225 条关于
“EPSCC”
全部
225
临床试验
214
药物
0
机构
0
资讯
11
10个月前
DURVASCC Trial Evaluates Durvalumab-Chemotherapy Combination for Rare Extrapulmonary Small Cell Carcinoma
去年
Neoadjuvant Immunochemoradiotherapy Shows Similar Efficacy to Chemoradiotherapy in ESCC
3年前
Socazolimab Plus Chemotherapy Shows Promise in Neoadjuvant Treatment for ESCC
2年前
Tislelizumab Approved in Israel for Advanced Esophageal Squamous Cell Carcinoma
去年
Onco360 Selected as National Pharmacy Partner for Tevimbra in ESCC Treatment
去年
European Commission Approves Tislelizumab Plus Chemotherapy for ESCC and GEJ Cancer
去年
UK Approves Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma
去年
Tislelizumab Plus Chemotherapy Poised for EU Approval in Gastric, GEJ Adenocarcinoma, and ESCC
去年
ODAC Weighs PD-L1 Expression as Predictive Biomarker for Immunotherapy in Esophageal Cancer
去年
PD-L1 Expression Thresholds in Gastrointestinal Cancers Under Scrutiny for PD-1 Inhibitor Efficacy
第 1 页,共 2 页
上一页
下一页